Early Detection of Cancer Conference 2026: fresh perspectives from Edinburgh
By Molly Donald, Cancer Sciences PhD student and Science Communication Ambassador
Fresh perspectives from Edinburgh
How can we detect cancer earlier – and what will it take to turn promising research into better outcomes for patients? These questions shaped the Early Detection of Cancer Conference, which I attended in Edinburgh from 6-8 October 2026.
Hosted by Cancer Research UK, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), and OHSU Knight Cancer Institute, the conference brought together researchers across disciplines to share new findings and explore the next steps for early detection.
Why early detection matters
When cancer is detected at an early stage, interventions are much more likely to be successful, in turn increasing survival rates. At the conference, researchers explored how understanding early-stage cancer biology can inform new detection and screening methods. Discussions also highlighted the need to involve patients at every stage of research.
Programme highlights
Professor Sam Janes from University College London opened the conference with a talk on lung cancer. He argued that research funding should prioritise finding cancer early and stopping it from developing, with a focus on understanding its biology.
Dr Faisal Mahmood (Harvard Medical School) explored how models that combine different types of patient data could help detect cancer earlier.
Professor Ros Eeles (Institute for Cancer Research) discussed using genetic risk to target prostate cancer screening.
A lively debate asked whether AI-assisted imaging could replace multi-cancer early detection (MCED) tests. Panels also explored how to reduce inequalities in early detection and discussed the opportunities and challenges of finding new markers that could help detect cancer earlier.
Emerging researchers gave short talks on MCED tests, cancer risk and the biology of early cancer, including models used to study it. On the final day, speakers explored how digital tools and different types of data could work together to improve patient outcomes.
I found the conference really insightful! Working in a research environment with a heavy focus on pharmacological targeting of established tumours, it was great to attend this meeting and see all the work going into different methods of early detection across individual cancers and multi-cancer early detection (MCEDs).
Emma Gasson
Cancer Sciences PhD student
Presenting my research
Presenting my research gave me the chance to discuss my findings with fellow researchers. Their questions and ideas helped me see my work from new angles and consider approaches I could explore. Their positive feedback was reassuring, too!
Beyond the immediate feedback on my research, it was also a fantastic opportunity to build connections with other researchers that could lead to future collaborations and opportunities. I would like to extend my gratitude to The University of Manchester Division of Cancer Sciences, who awarded me their Conference Support Fund, which allowed me to attend.
Making connections in Edinburgh
Edinburgh offered more than a beautiful backdrop. At the conference dinner at Dynamic Earth, a science museum in the city, we explored the exhibits before sitting down to eat. Throughout the event, conversations opened opportunities for new collaborations.
The organisers also made early career researchers feel welcome and valued. A dedicated early career dinner gave us the chance to meet the scientific programme committee and put our questions directly to them.
For me, the most exciting conversations at EDoC sat at the interface of somatic clonal evolution and signals of risk. Mutations accumulate in all of us, but only a small fraction progress to cancer. Understanding what tips that balance is what will improve early detection, and preclinical models that let us interrogate these early events will be central to that effort.
Dr William Hill
CRUK MI Cancer Origins group leader
Dr William Hill (CRUK Manchester Institute) gave an insightful talk on the signals and mechanisms of lung cancer promotion.
The panel explored how to reduce inequalities in early detection and discussed the opportunities and challenges of finding new markers that could help detect cancer earlier.
Manchester researchers in the spotlight
I enjoyed seeing familiar faces from Manchester contribute to the programme. Professor Samra Turajlic, Director of CRUK Manchester Institute, chaired a session on biology and early models of cancer, while Dr William Hill (CRUK MI) gave an insightful talk on the signals and mechanisms of lung cancer promotion.
What I’m taking back to Manchester
I left Edinburgh with fresh perspectives on my research and a renewed sense of purpose. The preclinical biology talks stood out for me, alongside discussions about how researchers can translate early models into clinical settings to benefit patients.
Hearing from passionate researchers – and sharing my own findings with them –reinforced why this work matters: understanding cancer’s earliest stages can help us find better ways to detect it.